Prognostic Significance of Programmed Cell Death‐Ligand 1 Expression in Tobacco Associated Oral Squamous Cell Carcinoma: An Immunohistochemical Based Cross‐Sectional Study
Journal of Oral Pathology & Medicine · 2024
DOI: 10.1111/jop.13584 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Oral Pathology & Medicine, 2024. Verfasst von Naga Naveena N und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Pathology & Microbiology, SCB Govt. Dental College and Hospital, Cuttack, India. Hauptthemen laut MEDLINE: Mouth Neoplasms, B7-H1 Antigen, Immunohistochemistry, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Background
Advancements in immuno‐oncology have dramatically transformed cancer treatment. Immunotherapy, targeting immune check point proteins, notably Programmed cell death ligand 1 (PD‐L1) and its receptor Programmed Cell Death‐1 (PD‐1) which modulate the activity of immune response in Head and Neck squamous cell carcinomas (HNSCC), is an area of much research. The immunohistochemical expression of PD‐L1 in cancer cells has been proposed as a predictive biomarker for selecting candidates for immunotherapy. Thus, the present study was undertaken to study the expression of PD‐L1 in the primary tumour cells and evaluate its correlation with various clinicopathological parameters and prognosis in tobacco associated oral squamous cell carcinomas (OSCC).
Methods
Expression of PD‐L1 was investigated in 75 surgically resected cases of OSCC by immunohistochemistry and its association with different clinicopathological features and prognosis was analysed.
Results
PD‐L1 protein was detected in 68% (51 cases) of cases. Tumour stage ( p = 0.04), lymph node (LN) metastasis ( p < 0.01) and moderate to marked tumour infiltrating lymphocytes (TILs) ( p < 0.05), significantly correlated with the PD‐L1 expression in the primary tumour. PD‐L1 expression did not show a significant association with overall survival (OS) rate, however, patients with positive PD‐L1 expression showed a poorer survival rate. Patients exhibiting nodal positivity had the worst prognosis ( p < 0.005).
Conclusion
These data demonstrated a significant association of ≥ 5% PD‐L1 expression in the primary tumour and the presence of LN metastasis, moderate to marked TILs and advancing tumour stage, thus, making it a plausible immunotherapeutic target molecule in OSCC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral Pathology & Microbiology, SCB Govt. Dental College and Hospital, Cuttack, India.
- Department of Oral Pathology & Microbiology, Institute of Dental Sciences, Siksha 'O' Anusandhan, Deemed to Be University, Bhubaneswar, India.
- Department of Public Health Dentistry, SCB Govt. Dental College & Hospital, Cuttack, India.
ORCID-Profile: Naga Naveena N, Sweta Mohanty, Surya Narayan Das, Rachna Rath, Sri Priya Narayanan
Zitieren
APA
N, N. N., Mohanty, S., Das, S. N., Rath, R., & Narayanan, S. P. (2024). Prognostic Significance of Programmed Cell Death‐Ligand 1 Expression in Tobacco Associated Oral Squamous Cell Carcinoma: An Immunohistochemical Based Cross‐Sectional Study. Journal of Oral Pathology & Medicine. https://doi.org/10.1111/jop.13584
Vancouver
N NN, Mohanty S, Das SN, Rath R, Narayanan SP. Prognostic Significance of Programmed Cell Death‐Ligand 1 Expression in Tobacco Associated Oral Squamous Cell Carcinoma: An Immunohistochemical Based Cross‐Sectional Study. Journal of Oral Pathology & Medicine. 2024. doi:10.1111/jop.13584
BibTeX
@article{N2024,
author = {N, Naga Naveena and Mohanty, Sweta and Das, Surya Narayan and Rath, Rachna and Narayanan, Sri Priya},
title = {Prognostic Significance of Programmed Cell Death‐Ligand 1 Expression in Tobacco Associated Oral Squamous Cell Carcinoma: An Immunohistochemical Based Cross‐Sectional Study},
journal = {Journal of Oral Pathology & Medicine},
year = {2024},
doi = {10.1111/jop.13584}
}
EUVIMED